Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Lancet. Diabetes & Endocrinology|December 4, 2023
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Influence of vitamin D supplementation on fracture risk, bone mineral density and bone biochemistry in Mongolian schoolchildren: multicenter double-blind randomized placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Vaccines|April 28, 2023
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster StrategyMadison Stoddard, Lin Yuan, Sharanya Sarkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Prevalence and Determinants of QuantiFERON-Diagnosed Tuberculosis Infection in 9810 Mongolian SchoolchildrenDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
Vaccines|May 7, 2025
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based AnalysisLin Yuan, Madison Stoddard, Sharanya Sarkar, et al.
Clinical and Translational Science|August 1, 2019
Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of AmphetamineElena S Izmailova, Ian L McLean, Greg Hather, et al.
Scientific Reports|February 28, 2020
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of ProtectionGinger Young, Kelly J Bohning, Melissa Zahralban-Steele, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
Cancer Research|October 27, 2012
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924Jonathan L Blank, Xiaozhen J Liu, Katherine Cosmopoulos, et al.
Pageof 5